Supernus Pharmaceuticals, Inc. (SUPN)
NASDAQ: SUPN · Real-Time Price · USD
31.99
+0.34 (1.07%)
At close: Mar 5, 2025, 4:00 PM
32.18
+0.19 (0.59%)
Pre-market: Mar 6, 2025, 6:39 AM EST
Supernus Pharmaceuticals Employees
Supernus Pharmaceuticals had 652 employees as of December 31, 2023. The number of employees increased by 40 or 6.54% compared to the previous year.
Employees
652
Change (1Y)
40
Growth (1Y)
6.54%
Revenue / Employee
$1,015,057
Profits / Employee
$113,290
Market Cap
1.79B
Employees Chart
SUPN News
- 1 day ago - Supernus to Participate in Two Upcoming Investor Conferences - GlobeNewsWire
- 6 days ago - Supernus to Participate in the TD Cowen 45th Annual Health Care Conference - GlobeNewsWire
- 8 days ago - Supernus Pharmaceuticals, Inc. (SUPN) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Supernus Announces Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 14 days ago - BREAKING: Supernus Pharmaceuticals, Inc. Shares Down 14%; Investors Should Contact Block & Leviton to Find Out How They Might Recover Money Through The Firm's Investigation - GlobeNewsWire
- 14 days ago - Supernus Pharmaceuticals Stock Falls On Disappointing Data From Treatment-Resistant Depression Trial - Benzinga
- 15 days ago - Supernus Announces Topline Results from Phase 2b Study in Adults with Treatment Resistant Depression - GlobeNewsWire
- 22 days ago - Supernus Pharmaceuticals to Host Conference Call and Webcast on February 25, 2025, to Discuss Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire